Detalles de la búsqueda
1.
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.
Cancer
; 118(19): 4694-705, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22434360
2.
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.
Oral Oncol
; 134: 106087, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126605
3.
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
N Engl J Med
; 359(11): 1116-27, 2008 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18784101
4.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Radiother Oncol
; 156: 281-293, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515668
5.
Primary pulmonary artery sarcoma: report of three cases and review of the literature.
Clin Lung Cancer
; 8(4): 277-81, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17311694
6.
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
J Clin Oncol
; 23(24): 5568-77, 2005 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16009950
7.
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
J Clin Oncol
; 23(34): 8636-45, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16275937
8.
Molecular biology in head and neck cancer.
Clin Transl Oncol
; 8(11): 776-9, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17134964
9.
Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC).
Cancers (Basel)
; 8(3)2016 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26927178
10.
Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Eur J Cancer
; 41(3): 453-60, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15691646
11.
Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Clin Cancer Res
; 10(24): 8486-92, 2004 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15623629
12.
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.
J Clin Oncol
; 31(23): 2854-60, 2013 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23835714
13.
Update on the diagnosis of cancer of unknown primary (CUP) origin.
Clin Transl Oncol
; 13(7): 434-41, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21775269
14.
Diagnosis of unknown primary cancer based on molecular techniques may influence therapeutic approach and improve survival.
Clin Transl Oncol
; 12(8): 574-5, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20709655
15.
Tyrosine kinase inhibitors in treating soft tissue sarcomas: sunitinib in non-GIST sarcomas.
Clin Transl Oncol
; 12(7): 468-72, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20615823
16.
Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma.
Clin Transl Oncol
; 11(7): 479-83, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19574207
17.
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
J Clin Oncol
; 25(16): 2171-7, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17538161
18.
Cetuximab in squamous cell carcinoma of the head and neck.
Future Oncol
; 2(4): 449-57, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16922611
19.
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Cancer
; 106(1): 106-11, 2006 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16329139
20.
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
J Clin Oncol
; 24(26): 4333-9, 2006 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16896002